{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-044758","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.919638+00:00","generated_at":"2026-06-24T03:57:43.898664+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sensus Healthcare Q2 revenue up 124% to $12.1M; diluted EPS $0.21 vs $(0.02) YoY","bullets":["Revenue $12.1M, up 124% from $5.4M in Q2 2021; net income $3.5M vs net loss $(0.3M).","Diluted EPS $0.21 vs $(0.02); adjusted EBITDA $4.7M vs $(0.1M).","Gross margin improved to 68.6% from 61.1%; cash and equivalents $33.7M.","Received orders for 10 TransDermal Infusion Systems from Hair Enhancement Centers.","Affirms expectations for continued Q3 growth and full-year profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-044758","json":"https://secwatch.observer/filing/0001213900-22-044758.json","markdown":"https://secwatch.observer/filing/0001213900-22-044758.md","text":"https://secwatch.observer/filing/0001213900-22-044758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/0001213900-22-044758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/ea163775-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:57:43.898664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}